Lymphatica Medtech

Lymphatica Medtech is a Lausanne-based clinical-stage company specializing in innovative therapies for lymphedema, aiming to reconstruct personal impacts on lymphatic circulation caused by lymphedema. The company has developed the first active implantable lymphatic bypass, consisting of an implantable magnetically controlled micropump and catheters that drain lymphatic fluid internally from multiple points in the affected limb, enabling patients to effectively treat lymphedema.